Please ensure Javascript is enabled for purposes of website accessibility

Survey: 58% of Americans Don't Know the Difference Between CBD, THC, and Marijuana

By Rich Duprey - Updated Apr 8, 2021 at 12:52PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It matters because ignorance is not bliss when it comes to creating broad market acceptance.

For most people following the cannabis space, the differences among cannabidiol (CBD), tetrahydrocannabinol (THC), and marijuana are clear. But the vast majority of Americans are not familiar with the differences, and that ignorance makes the broader acceptance of CBD products in the marketplace more difficult, according to a survey released this month.

Data from Invisibly's Realtime Research survey of 1,087 people shows 58% of respondents didn't know the difference between CBD and THC-containing products such as marijuana.

While it's right to assume that people who don't use CBD or marijuana don't realize there is a difference between the psychoactive compound THC and the non-psychoactive CBD (68% of such people were unaware, the survey showed), what's more surprising is that less than two-thirds of those who had consumed CBD understood there was a difference between the compounds.

Green beverages with marijuana leaves

Image source: Getty Images.

That means 36% of those taking CBD didn't know they were ingesting something very different from THC-containing marijuana. It suggests many people may be taking CBD products thinking the effects would be similar to marijuana.

It may also be why many won't try CBD products to begin with. Some 53% of respondents who had not tried CBD say they will not use it for any reason.

Although non-users are in the majority, Invisibly says the survey found people across the board are considering CBD products, though women are the ones who use them more, by over 2 to 1.

As more CBD products enter the market, resistance to usage could fall. Canopy Growth (CGC -6.16%) and HEXO (HEXO -8.41%), for example, have extensive lines of beverages available in Canada, while Charlotte's Web (CWBHF -10.13%) is the No. 1 wholesaler of CBD in North America with a broad range of edibles, gummies, topicals, tinctures, and more. 

Invisibly also found relief from stress, anxiety, and pain were the main reasons for CBD use.

Rich Duprey has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Charlotte's Web Holdings. The Motley Fool recommends HEXO Corp.. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Canopy Growth Stock Quote
Canopy Growth
CGC
$3.81 (-6.16%) $0.25
HEXO Stock Quote
HEXO
HEXO
$0.23 (-8.41%) $0.02
Charlotte's Web Holdings, Inc. Stock Quote
Charlotte's Web Holdings, Inc.
CWBHF
$0.68 (-10.13%) $0.08

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
394%
 
S&P 500 Returns
127%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.